172 related articles for article (PubMed ID: 18397234)
1. Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.
Sermasathanasawadi R; Kato N; Muroyama R; Dharel N; Shao RX; Chang JH; Li CZ; Kawabe T; Omata M
Liver Int; 2008 Jul; 28(6):798-806. PubMed ID: 18397234
[TBL] [Abstract][Full Text] [Related]
2. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
4. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
Yee LJ; Tang J; Herrera J; Kaslow RA; van Leeuwen DJ
Genes Immun; 2000 Aug; 1(6):386-90. PubMed ID: 11196686
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of interferon-gamma gene at position +874 and clinical characteristics of chronic hepatitis C.
Dai CY; Chuang WL; Hsieh MY; Lee LP; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
Transl Res; 2006 Sep; 148(3):128-33. PubMed ID: 16938650
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.
Bouzgarrou N; Hassen E; Farhat K; Bahri O; Gabbouj S; Maamouri N; Ben Mami N; Saffar H; Trabelsi A; Triki H; Chouchane L
Hum Immunol; 2009 Apr; 70(4):230-6. PubMed ID: 19480854
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H
J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.
Nalpas B; Lavialle-Meziani R; Plancoulaine S; Jouanguy E; Nalpas A; Munteanu M; Charlotte F; Ranque B; Patin E; Heath S; Fontaine H; Vallet-Pichard A; Pontoire D; Bourlière M; Casanova JL; Lathrop M; Bréchot C; Poynard T; Matsuda F; Pol S; Abel L
Gut; 2010 Aug; 59(8):1120-6. PubMed ID: 20587546
[TBL] [Abstract][Full Text] [Related]
11. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection.
Papatheodoridis GV; Paraskevis D
Liver Int; 2008 Jul; 28(6):764-6. PubMed ID: 18647140
[No Abstract] [Full Text] [Related]
12. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F
J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137
[TBL] [Abstract][Full Text] [Related]
13. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.
Falleti E; Cmet S; Fabris C; Bitetto D; Cussigh A; Fornasiere E; Bignulin E; Feruglio C; Mosanghini E; Fontanini E; Pirisi M; Toniutto P
Cytokine; 2012 Jan; 57(1):68-73. PubMed ID: 22122913
[TBL] [Abstract][Full Text] [Related]
14. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
Bouzgarrou N; Hassen E; Schvoerer E; Stoll-Keller F; Bahri O; Gabbouj S; Cheikh I; Maamouri N; Mammi N; Saffar H; Trabelsi A; Triki H; Chouchane L
J Med Virol; 2008 Apr; 80(4):607-14. PubMed ID: 18297714
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
Tsukada H; Ochi H; Maekawa T; Abe H; Fujimoto Y; Tsuge M; Takahashi H; Kumada H; Kamatani N; Nakamura Y; Chayama K
Gastroenterology; 2009 May; 136(5):1796-805.e6. PubMed ID: 19208361
[TBL] [Abstract][Full Text] [Related]
16. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C.
Richardson MM; Powell EE; Barrie HD; Clouston AD; Purdie DM; Jonsson JR
J Med Genet; 2005 Jul; 42(7):e45. PubMed ID: 15994870
[TBL] [Abstract][Full Text] [Related]
17. UDP-glucuronosyltransferase 1A7 polymorphisms are associated with liver cirrhosis.
Tang KS; Lee CM; Teng HC; Huang MJ; Huang CS
Biochem Biophys Res Commun; 2008 Feb; 366(3):643-8. PubMed ID: 18054330
[TBL] [Abstract][Full Text] [Related]
18. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
Schott E; Witt H; Neumann K; Taube S; Oh DY; Schreier E; Vierich S; Puhl G; Bergk A; Halangk J; Weich V; Wiedenmann B; Berg T
J Hepatol; 2007 Aug; 47(2):203-11. PubMed ID: 17512627
[TBL] [Abstract][Full Text] [Related]
19. [Genetics factors determining predisposition to chronic course of virus hepatitis and fibrosis in liver].
Goncharova IA; Beloborodova EV; Freĭdin MB; Beloborodova EI; Chernogoriuk GE; Puzyrev VP
Mol Biol (Mosk); 2008; 42(2):238-41. PubMed ID: 18610831
[TBL] [Abstract][Full Text] [Related]
20. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
Schott E; Witt H; Pascu M; van Boemmel F; Weich V; Bergk A; Halangk J; Müller T; Puhl G; Wiedenmann B; Berg T
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):947-51. PubMed ID: 18049163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
